The impact of RNA extraction method on accurate RNA sequencing from formalin-fixed paraffin-embedded tissues

[1]  Kuanyu Wang,et al.  A novel DNA damage response signature of IDH-mutant grade II and grade III astrocytoma at transcriptional level , 2020, Journal of Cancer Research and Clinical Oncology.

[2]  A. Viale,et al.  SETER/PR: a robust 18-gene predictor for sensitivity to endocrine therapy for metastatic breast cancer , 2019, npj Breast Cancer.

[3]  E. Domany,et al.  mRNA-seq whole transcriptome profiling of fresh frozen versus archived fixed tissues , 2018, BMC Genomics.

[4]  Christian G Bien,et al.  Systematic evaluation of RNA quality, microarray data reliability and pathway analysis in fresh, fresh frozen and formalin-fixed paraffin-embedded tissue samples , 2018, Scientific Reports.

[5]  T. Speed,et al.  Accurate RNA Sequencing From Formalin-Fixed Cancer Tissue to Represent High-Quality Transcriptome From Frozen Tissue , 2018, JCO precision oncology.

[6]  Chungyeul Kim,et al.  Optimization of RNA Extraction from Formalin-Fixed Paraffin-Embedded Blocks for Targeted Next-Generation Sequencing , 2017, Journal of breast cancer.

[7]  P. Simpson,et al.  Molecular signatures in breast cancer. , 2017, Methods.

[8]  S. Schuierer,et al.  A comprehensive assessment of RNA-seq protocols for degraded and low-quantity samples , 2017, BMC Genomics.

[9]  S. Heath,et al.  A Comparison of RNA-Seq Results from Paired Formalin-Fixed Paraffin-Embedded and Fresh-Frozen Glioblastoma Tissue Samples , 2017, PloS one.

[10]  Na Li,et al.  Robust transcriptional tumor signatures applicable to both formalin-fixed paraffin-embedded and fresh-frozen samples , 2016, Oncotarget.

[11]  Joel S. Parker,et al.  Genefu: an R/Bioconductor package for computation of gene expression-based signatures in breast cancer , 2016, Bioinform..

[12]  J. Carpten,et al.  Translating RNA sequencing into clinical diagnostics: opportunities and challenges , 2016, Nature Reviews Genetics.

[13]  Ying Li,et al.  Measure transcript integrity using RNA-seq data , 2016, BMC Bioinformatics.

[14]  Christoph Ziegenhain,et al.  The impact of amplification on differential expression analyses by RNA-seq , 2016, Scientific Reports.

[15]  Peter Beyerlein,et al.  Robust gene expression and mutation analyses of RNA-sequencing of formalin-fixed diagnostic tumor samples , 2015, Scientific Reports.

[16]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[17]  C. Sotiriou,et al.  Transfer of clinically relevant gene expression signatures in breast cancer: from Affymetrix microarray to Illumina RNA-Sequencing technology , 2014, BMC Genomics.

[18]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[19]  Sheng Li,et al.  Multi-platform assessment of transcriptome profiling using RNA-seq in the ABRF next-generation sequencing study , 2014, Nature Biotechnology.

[20]  David P. Kreil,et al.  A comprehensive assessment of RNA-seq accuracy, reproducibility and information content by the Sequencing Quality Control consortium , 2014, Nature Biotechnology.

[21]  D. Bates,et al.  Fitting Linear Mixed-Effects Models Using lme4 , 2014, 1406.5823.

[22]  Anne-Mette K. Hein,et al.  Next-Generation Sequencing of RNA and DNA Isolated from Paired Fresh-Frozen and Formalin-Fixed Paraffin-Embedded Samples of Human Cancer and Normal Tissue , 2014, PloS one.

[23]  Y. Gilad,et al.  RNA-seq: impact of RNA degradation on transcript quantification , 2014, BMC Biology.

[24]  Björn Usadel,et al.  Trimmomatic: a flexible trimmer for Illumina sequence data , 2014, Bioinform..

[25]  Krishna R. Kalari,et al.  Gene Expression, Single Nucleotide Variant and Fusion Transcript Discovery in Archival Material from Breast Tumors , 2013, PloS one.

[26]  Aviv Regev,et al.  Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples , 2013, Nature Methods.

[27]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..

[28]  Wei Li,et al.  RSeQC: quality control of RNA-seq experiments , 2012, Bioinform..

[29]  L. Pusztai,et al.  Effects of tissue handling on RNA integrity and microarray measurements from resected breast cancers. , 2011, Journal of the National Cancer Institute.

[30]  Colin N. Dewey,et al.  RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome , 2011, BMC Bioinformatics.

[31]  R. Greil,et al.  A New Molecular Predictor of Distant Recurrence in ER-Positive, HER2-Negative Breast Cancer Adds Independent Information to Conventional Clinical Risk Factors , 2011, Clinical Cancer Research.

[32]  Peter Regitnig,et al.  Genomic index of sensitivity to endocrine therapy for breast cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  T. Eberlein A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer , 2006 .

[34]  Charles Auffray,et al.  Towards standardization of RNA quality assessment using user-independent classifiers of microcapillary electrophoresis traces , 2005, Nucleic acids research.

[35]  M. Cronin,et al.  A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. , 2004, The New England journal of medicine.

[36]  L. Lin,et al.  A concordance correlation coefficient to evaluate reproducibility. , 1989, Biometrics.